RecombiMAb human IgG1 (LALA-PG) isotype control, anti-respiratory syncytial virus

Clone Palivizumab-CP161
Catalog # CP161
Category in vivo Recombinant Antibodies
Price
Size Regular Price
1mg $ 217.00
5mg $ 843.00
25mg $ 2,942.00
50mg $ 4,229.00
100mg $ 5,910.00
About RecombiMAb human IgG1 (LALA-PG) isotype control, anti-respiratory syncytial virus

This human IgG1 isotype control antibody reacts with respiratory syncytial virus and has low or no specific binding to any human sample. The P329G substitution combined with L234A and L235A (LALA-PG) has been shown to decrease effector functions by disrupting the Fc/Fcγ receptor interface.

RecombiMAb human IgG1 (LALA-PG) isotype control, anti-respiratory syncytial virus Specifications
IsotypeHuman IgG1
Recommended Dilution BufferInVivoPure pH 7.0 Dilution Buffer
MutationsL234A, L235A, P329G (LALA-PG)
FormulationPBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin<1EU/mg (<0.001EU/μg)
Determined by LAL gel clotting assay
Purity>95%
Determined by SDS-PAGE
Sterility0.2 µm filtration
ProductionPurified from CHO cell supernatant
PurificationProtein G
Molecular Weight150 kDa
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Application References